- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 33/26 - Iron; Compounds thereof
Patent holdings for IPC class A61K 33/26
Total number of patents in this class: 1249
10-year publication summary
96
|
125
|
96
|
105
|
114
|
122
|
134
|
140
|
99
|
32
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
SBI Pharmaceuticals Co., Ltd. | 108 |
46 |
Société des Produits Nestlé S.A. | 9672 |
31 |
Vifor Fresenius Medical Care Renal Pharma Ltd. | 34 |
21 |
Pharmacosmos Holding A/S | 119 |
17 |
Vifor (International) AG | 143 |
16 |
CEVA Sante Animale | 683 |
13 |
ThermoLife International, LLC | 118 |
12 |
Nanobacterie | 33 |
11 |
National Center for Child Health and Development | 71 |
11 |
Alesco SRL | 73 |
10 |
Biolife, L.L.C. | 59 |
10 |
Shield TX (UK) Ltd. | 32 |
10 |
The General Hospital Corporation | 4517 |
9 |
Panion & BF Biotech Inc. | 15 |
8 |
The University of Tokyo | 3903 |
8 |
The Regents of the University of California | 18943 |
7 |
DSM IP Assets B.V. | 5856 |
7 |
Board of Regents, The University of Texas System | 5370 |
7 |
EirGen Pharma Limited | 91 |
7 |
Renibus Therapeutics, Inc. | 32 |
7 |
Other owners | 981 |